Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example

被引：17
作者：
Altraif, Ibrahim [1 ]
机构：
[1] King Abdul Aziz Med City, Minist Natl Guard Hosp Hlth Affairs, Hepatobiliary Sci & Organ Transplant Ctr, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia
来源：
SAUDI MEDICAL JOURNAL | 2018年 / 39卷 / 08期
关键词：
Elimination; HCV; Saudi Arabia;
D O I：
10.15537/smj.2018.8.22467
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：842 / 845
页数：4
相关论文
共 6 条
[1]   HCV genotypes among 1013 Saudi nationals: a multicenter study [J].
Al Traif, Ibrahim ;
Al Balwi, Mohammed A. ;
Abdulkarim, Ibrahim ;
Handoo, Fayaz A. ;
Alqhamdi, Hamdan Saleh ;
Alotaibi, Melfi ;
Aljumah, Abdulrahman ;
Al Ashqar, Hamad Ibrahim ;
Bzeizi, Khalid ;
Al Quaiz, Mohammed ;
Alalwan, Abduljaleel ;
Al Hamoudi, Waleed ;
Alswat, Khalid ;
Sanai, Faisal ;
Abdo, Ayman .
ANNALS OF SAUDI MEDICINE, 2013, 33 (01) :10-12
[2]   Epidemiology, Disease Burden, and Treatment Strategies of Chronic Hepatitis C Virus Infections in Saudi Arabia in the New Treatment Paradigm Shift [J].
Aljumah, Abdulrahman A. ;
Abaalkhail, Faisal ;
Al-Ashgar, Hamad ;
Assiri, Abdullah ;
Babatin, Mohamed ;
Al Faleh, Faleh ;
Alghamdi, Abdullah ;
Al-Hakeem, Raafat ;
Hashim, Almoataz ;
Alqutub, Adel ;
Razavi, Homie ;
Sanai, Faisal M. ;
Al-Swat, Khalid ;
Schmelzer, Jonathan ;
Altraif, Ibrahim .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (04) :269-281
[3]   Eliminating viral hepatitis: time to match visions with action [J].
不详 .
LANCET, 2017, 390 (10108) :2121-2121
[4]   Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy [J].
Banerjee, D. ;
Reddy, K. R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (06) :674-696
[5]   The use of generic medications for hepatitis C [J].
Freeman, James A. D. ;
Hill, Andrew .
LIVER INTERNATIONAL, 2016, 36 (07) :929-932
[6]  
World Health Organization, EL HEP
1